Sweetgreen Slashes FY26 Outlook as Cyclosporiasis Outbreak Hammers Demand; Q2 Loss Widens
SG is trading near its 52-week low of $4.49 (11% above the low).
Summary
Sweetgreen cut its FY26 same-store sales guidance to a 7-8% decline from the prior 2-4% drop, citing the cyclosporiasis outbreak's impact on demand. Q2 results underscore the damage: loss widened to $26.3M from $23.2M a year ago, revenue of $192.7M missed estimates, and same-store sales fell 6.2%—worse than the expected 4% decline. The stock tumbled 16% after hours to $4.93, adding to a 28% slide over the past month. This follows the July 16 news of the outbreak-linked market cap loss, but today's numbers quantify the financial hit and management's lowered expectations. The company is leaning on new restaurant openings and menu innovation like wraps, but the near-term outlook is grim with traffic down 2% and product mix pressured by promotions.
At the time of this announcement, SG was trading at $4.97 on NYSE in the Trade & Services sector, with a market capitalization of approximately $697.5M. The 52-week trading range was $4.49 to $12.80. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.